Business

Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem

Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced full commercial launch of the InSet™ I-135RFX Humeral Stem ("InSet™ I-135RFX").

articleShoulder Innovations, Inc.April 27, 20262/company/shoulder-innovations-inc/news/shoulder-innovations-initiates-full-commercial-launch-of-the-insettm-i-135rfx-humeral-stem
Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem

About this update from Shoulder Innovations, Inc.

[{"type":"text","content":"Latest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDAClearance of Additional Fracture Indications","length":137,"tagName":"p","attribs":{}},{"type":"text","content":"GRAND RAPIDS, Mich., April 27, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced full commercial launch of the InSet™ I-135RFX Humeral Stem ("InSet™ I-135RFX").","length":357,"tagName":"p"},{"type":"image","alt":"Shoulder Innovations company logo (PRNewsfoto/Shoulder Innovations)","displaySize":"","headline":null,"caption":"Shoulder Innovations company logo (PRNewsfoto/Shoulder Innovations)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":107,"url":"https://media.zenfs.com/en/prnewswire.com/8a1402851f2d0708bf3061fb1fe462a9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/urlxYGPEipaOXgo73Rrq0g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE4OQ--/https://media.zenfs.com/en/prnewswire.com/8a1402851f2d0708bf3061fb1fe462a9","width":400,"height":107}},"href":"https://mma.prnewswire.com/media/779412/Shoulder_Innovations_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The commencement of full launch follows a successful limited market release and receipt of additional FDA 510(k) clearance for an expanded set of fracture indications, enabling the InSet™ I-135RFX to now be utilized in all primary, revision, and fracture total shoulder arthroplasty procedures.","length":294,"tagName":"p"},{"type":"text","content":""The addition of the InSet I-135RFX to our best-in-class suite of shoulder surgical care solutions is an important milestone for SI, enabling us to now support the full spectrum of shoulder arthroplasty procedures our surgeon customers perform," said Rob Ball, CEO of Shoulder Innovations. "As the third addition to our InSet Humeral Stem System in as many years, this launch reflects the strength of our innovation engine and our commitment to delivering meaningful improvements in patient outcomes, even in the most challenging of clinical scenarios."","length":573,"tagName":"p"},{"type":"text","content":"The InSet™ I-135RFX joins the smaller form factor InSet™ ...

More updates from Shoulder Innovations, Inc.

shoulder arthroplastysurgical carereverse shoulder arthroplastyInnovationsmedical technology company